LLY

917.82

+3.36%↑

JNJ

243.26

+0.5%↑

ABBV

216.83

+1.6%↑

NVS

151.64

+0.81%↑

MRK

119.41

+1.21%↑

LLY

917.82

+3.36%↑

JNJ

243.26

+0.5%↑

ABBV

216.83

+1.6%↑

NVS

151.64

+0.81%↑

MRK

119.41

+1.21%↑

LLY

917.82

+3.36%↑

JNJ

243.26

+0.5%↑

ABBV

216.83

+1.6%↑

NVS

151.64

+0.81%↑

MRK

119.41

+1.21%↑

LLY

917.82

+3.36%↑

JNJ

243.26

+0.5%↑

ABBV

216.83

+1.6%↑

NVS

151.64

+0.81%↑

MRK

119.41

+1.21%↑

LLY

917.82

+3.36%↑

JNJ

243.26

+0.5%↑

ABBV

216.83

+1.6%↑

NVS

151.64

+0.81%↑

MRK

119.41

+1.21%↑

Начало・Списък с акции・ResMed Inc

ResMed Inc

Отворен

СекторЗдравеопазване

224.46 2.06

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

218.73

Максимум

224.6

Ключови измерители
By Trading Economics
Приходи	44M 393M
Продажби	87M 1.4B
P/E Средно за сектора	22.571 57.05
Дивидентна доходност	1
Марж на печалбата	27.593
Служители	10,600
EBITDA	63M 566M

Препоръки
By TipRanks
Препоръки	Купи
12-месечна прогноза	+34.35% upside

Дивиденти
By Dow Jones
Дивидентна доходност Средно за сектора	1.00% 2.52%
Следващи печалби	22.04.2026 г.
Следваща дата на дивидент	11.06.2026 г.
Следваща дата на екс-дивидент	7.05.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-4B 33B
Предишно отваряне	222.4
Предишно затваряне	224.46

Настроения в новините

By Acuity

27%

73%

83 / 349 Класиране в Healthcare

ResMed Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

30.03.2026 г., 23:15 ч. UTC

Значими събития в новините

U.K. Shoppers Paid a Little More This Month But Worse May yet Lie Ahead

30.03.2026 г., 22:36 ч. UTC

Значими събития в новините

Australian Government Rules Out Boots on the Ground in the Middle East

30.03.2026 г., 22:13 ч. UTC

Придобивния, сливания и поглъщания

Sun Life Financial Agrees to Buy Bell Partners for $350 Million

30.03.2026 г., 21:00 ч. UTC

Печалби

Aktis Oncology Gets FDA Clearance for Phase 1 Billion Trial of Tumor Treatment

30.03.2026 г., 20:15 ч. UTC

Значими събития в новините

Fed's Williams: Middle-East Developments Have Added Significant Economic Uncertainty

30.03.2026 г., 23:40 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

30.03.2026 г., 23:40 ч. UTC

Пазарно говорене

Nikkei May Decline on Higher Energy Cost Concerns -- Market Talk

30.03.2026 г., 23:36 ч. UTC

Пазарно говорене

Gold Edges Lower Amid Divergent Signals on U.S.-Iran Talks -- Market Talk

30.03.2026 г., 23:12 ч. UTC

Пазарно говорене

Alcoa Earnings Outlook Boosted by Market Disruptions -- Market Talk

30.03.2026 г., 22:49 ч. UTC

Пазарно говорене

Fed's Williams: Core Inflation Forecast Is Little Changed -- Market Talk

30.03.2026 г., 22:44 ч. UTC

Пазарно говорене

Fed's Williams: Risks to Both Sides of Dual Mandate Higher -- Market Talk

30.03.2026 г., 22:43 ч. UTC

Пазарно говорене

Fed's Williams Says Focus Is on Inflation Expectations Being Well Anchored -- Market Talk

30.03.2026 г., 22:42 ч. UTC

Пазарно говорене

South32 Should Go for Growth, Says New Bull -- Market Talk

30.03.2026 г., 22:18 ч. UTC

Пазарно говорене

Paragon Care's Chances of Using Levy to Pass on Higher Costs `Close to Zero' -- Market Talk

30.03.2026 г., 22:05 ч. UTC

Пазарно говорене

Northern Star's New Bull Argues Case for Asset Sales -- Market Talk

30.03.2026 г., 21:58 ч. UTC

Придобивния, сливания и поглъщания

Sun Life Financial Agrees to Buy Bell Partners for $350M

30.03.2026 г., 21:39 ч. UTC

Придобивния, сливания и поглъщания

Sun Life Sees 1Q Charge to Net of C$236M From BGO, Crescent Deals

30.03.2026 г., 21:38 ч. UTC

Придобивния, сливания и поглъщания

Sun Life: Completes Remaining Equity Interest Purchases of BGO, Crescent Capital

30.03.2026 г., 21:36 ч. UTC

Придобивния, сливания и поглъщания

Sun Life to Buy Fully Bell Partners for $350M >SLF.T

30.03.2026 г., 21:33 ч. UTC

Придобивния, сливания и поглъщания

Unilever Shareholders Expected to Own Two-Thirds of New Food Entity, Sources Say -- WSJ

30.03.2026 г., 21:33 ч. UTC

Придобивния, сливания и поглъщания

Unilever Nears Deal to Create $60 Billion Food Giant With McCormick -- WSJ

30.03.2026 г., 21:33 ч. UTC

Придобивния, сливания и поглъщания

Deal Could Be Announced As Soon As Tuesday, Sources Say -- WSJ

30.03.2026 г., 21:33 ч. UTC

Придобивния, сливания и поглъщания

Unilever Nears Cash-and-Stock Deal to Combine Food Business With McCormick, Sources Say -- WSJ

30.03.2026 г., 21:33 ч. UTC

Придобивния, сливания и поглъщания

Deal Set to Value Combined Food Business At Around $60B Including Debt, Sources Say -- WSJ

30.03.2026 г., 21:25 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

30.03.2026 г., 21:25 ч. UTC

Пазарно говорене

Warehouse Showing Cost Discipline But Margin Goal at Risk -- Market Talk

30.03.2026 г., 21:03 ч. UTC

Придобивния, сливания и поглъщания

Sun Life: Completes Equity Interest Purchases of BGO and Crescent Cap, Announces Acquisition of Bell Partners, a Multifamily Real Estate Investment Manager

30.03.2026 г., 20:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

30.03.2026 г., 20:09 ч. UTC

Печалби

This Stock Looks Like a Solid AI Bet -- and Wall Street Hasn't Noticed Yet -- Barrons.com

30.03.2026 г., 20:00 ч. UTC

Значими събития в новините

Fed's Williams: Middle-East Conflict 'Will Likely Boost Overall Inflation in Coming Months'

Сравнение с други в отрасъла

Ценова промяна

ResMed Inc Прогноза

Ценова цел

By TipRanks

34.35% нагоре

12-месечна прогноза

Среден 296.2 USD 34.35%

Висок 345 USD

Нисък 265 USD

Според 12 анализатори от Wall Street, предложили 12-месечна ценова цел за ResMed Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

12 ratings

Купи

Задържане

Продай

Според 12 анализатори, дали борсови рейтинги на ResMed Inc през последните 3 месеца.

Настроение

By Acuity

83 / 349 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно ResMed Inc

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.